Delivery Order SPE2DB24D1034-SPE2DB24FWCB5
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $2,902.70 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of August 26, 2024 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,959.79 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,333.96 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a June 2024 completion date. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $39,683.30 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a completion date of August 14, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical products and supplies to military treatment facilities,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,877.34 firm-fixed price delivery order is for the supply of OZEMPIC 0.25-0.5 mg/dose pens. This contract has an ultimate completion date of August 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., leverages its extensive supply chain to provide a wide range of medications and medical supplies to various government...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award, valued at $24,758.99, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. This is a firm fixed-price delivery order contract, with an ultimate completion date of August 20, 2024. The contract was not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $9,550.87 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The award is not under a set-aside program. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, holding significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,483.24 firm-fixed-price delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 ml. The contract has a ceiling value of $3,483.24 and a performance period ending on July 17, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,998.22 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a period of performance through August 16, 2024. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support...
This federal contract award is a delivery order worth $1,749.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ozempic 0.25-0.5 mg/dose pens. The contract was awarded by the Defense Logistics Agency (DLA) on March 22, 2024 and has a firm fixed price with a completion date of March 25, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded...